APA

Seino Y., Takami A., Boka G., Niemoeller E. & Raccah D. (20150330). Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin. : Diabetes, obesity & metabolism.

Chicago

Seino Y, Takami A, Boka G, Niemoeller E and Raccah D. 20150330. Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin. : Diabetes, obesity & metabolism.

Harvard

Seino Y., Takami A., Boka G., Niemoeller E. and Raccah D. (20150330). Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin. : Diabetes, obesity & metabolism.

MLA

Seino Y, Takami A, Boka G, Niemoeller E and Raccah D. Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin. : Diabetes, obesity & metabolism. 20150330.